The aim of this review is to summarize the current knowledge of TFEB-mediated lysosomal biogenesis and autophagy in NDs such as AD and PD, providing novel insight into understanding the pathogenesis of neurodegenerative diseases and the therapeutic potential of TFEB activators. The gene discussed is TFEB; the disease is Alzheimer disease.